Home
Live Updates
Cellectis Reports Financial Results For First Quarter 2024 : comparemela.com
Cellectis Reports Financial Results For First Quarter 2024
. Cellectis announced completion of the additional equity investment of $140M by AstraZeneca . Cash position of $143 million as of March 31
Related Keywords
France ,
United States ,
United Kingdom ,
Marc Dunoyer ,
Bing Wang ,
Nasdaq ,
International Accounting Standards Board ,
Cellectis The Company Euronext Growth ,
Allogeneic Car Development Programs ,
European Union ,
Research Plan ,
Astrazeneca ,
International Financial Reporting Standards ,
Euronext Growth ,
Chief Executive Officer ,
Development Programs ,
Investment Agreements ,
Arthur Stril ,
Interim Chief Financial Officer ,
Tyrell Rivers ,
Subsequent Investment Agreement ,
Net Income ,
Regarding Use ,
North Carolina ,
comparemela.com © 2020. All Rights Reserved.